Pfizer Buys King Pharma for $3.6 Billion

With King in its fold, Pfizer -- which makes Lyrica and Celebrex -- believes it can build an industry-leading portfolio of pain relievers. Among King's most appealing entrants in that market is the new Embeda, designed to prevent misuse and abuse.

New Gmail feature fights phishing

gmail phishing iconFor a while Google has been protecting users of its popular Gmail service from phishing e-mails by rejecting any message it knows is fake from...